EU Biosimilar Guidance Offers Window To Bypass Comparative Trials
Executive Summary
Manufacturers seeking regulatory approval of a follow-on biologic in the EU may be able to forgo clinical comparability trials under certain conditions, according to final guidelines on similar biologics issued by the European Medicines Agency March 8
You may also be interested in...
Generic Lovenox In EU Will Require Clinical Data, Shrinking Sandoz’s Opportunity
An EU guidance issued earlier this year requiring clinical trials for generic copies of low molecular weight heparins may just have shot the European market opportunity for Momenta and its partner Sandoz, according to Momenta's CFO Rick Shea
Generic Lovenox In EU Will Require Clinical Data, Shrinking Sandoz’s Opportunity
An EU guidance issued earlier this year requiring clinical trials for generic copies of low molecular weight heparins may just have shot the European market opportunity for Momenta and its partner Sandoz, according to Momenta's CFO Rick Shea
Lovenox Generics Might Be Slowed In U.S. Because Of EU Guidance, Sanofi Hopes
Sanofi-Aventis says an emerging European guideline prescribing clinical trials for low molecular weight heparin generics could sway FDA as it considers copies of its clot-busting blockbuster Lovenox